Navigation Links
US Patent Granted To Chrono Therapeutics Inc. For Its Chrono-Pharmacological Drug Delivery Systems And Applications
Date:6/4/2010

Patent Protection extends at least to 2025

Hamilton, NJ (PRWEB) June 4, 2010 -- Chrono Therapeutics Inc. (Chrono), a privately held company that pioneers chrono therapeutic health care products, announced today that it has been awarded another United States patent to protect its chrono-pharmacological systems and applications.

Guy DiPierro, CEO of Chrono, noted that this new patent grant enhances Chrono’s exclusivity for what is believed to be the next revolutionary change in therapeutics-namely tailored chrono-pharmacological therapies. Mr DiPierro noted that this new patent grant also affirms the novelty of Chrono’s technology and believes it will considerably reduce any potential risk to the Chrono group.

About Chrono Therapeutics Inc. Intellectual Property (IP)

Chrono Therapeutics’ IP estate includes issued, allowed, and granted fundamental patents in several of the world’s major pharmaceutical markets. This IP protects Chrono’s chrono-pharmacological applications and non-invasive drug delivery systems. Additional patents are and will soon be pending worldwide.

About Chrono Therapeutics Inc.

Chrono Therapeutics Inc. is specialty pharmaceutical company developing novel therapeutic systems and methods to become the global leader in Chrono Therapeutic based drug products. The significant advantages of chrono therapeutic based therapies have now become widely recognized and are quickly coming to the forefront as the next major advance in treating indications. The company is applying its therapeutic expertise to develop these chrono therapeutic and tailored applications that seek to dramatically increase efficacy over traditional non-tailored applications while decreasing adverse side effects and accumulated tolerance. The company’s leadership with chrono therapeutic optimized application and methodologies and fundamental patents, technology, and know-how has proven key in forming major alliances with leading companies worldwide.

Contact:
Chrono Therapeutics Inc.
Guy DiPierro, Chief Executive Officer
Email: Info(at)ChronoDose(dot)com
Website: www.ChronoDose.com

###

Read the full story at http://www.prweb.com/releases/CHRONO2010/06/prweb4084784.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dr. Jay Calvert MD Announces Details on New Patent-Protected Investigational Breast Implants
2. Haemonetics Files a New Legal Action to Stop Fenwal Inc.s Continued Patent Infringement
3. United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software
4. OmniActive and Kemin Reach Amicable Settlement in Patent Dispute
5. Patent Granted on GenerOs EX, A Medical Device That Helps Bones Grow
6. American Diversified Holdings Corporation Announces Stem Cell Patent Acquisition Program
7. MindUp (HIRU) Patents in the World Patent Database
8. GenomeQuest Hosts Seminar Focused On Web-based Searching for Patent Information Across Global Sequence Databases
9. Verdan Receives Patent on Crystal Deodorant Spray
10. My1Stop.com Expands Into Medical Wristbands Market with Patented LaserBand Printable Wristbands
11. Sandata Technologies and Infocrossing Settle Patent Infringement Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... , ... Students attending Envision’s summer 2017 National Youth ... experience in an emergency medical simulation, When Care is Hours Away. This dynamic ... skills that are critical success in a future career and beyond. , The ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is a ... smoothing and tightening the skin of the face to create more youthful features. ... with very little downtime, Silhouette Instalift is a novel, minimally invasive facial procedure ...
(Date:12/7/2016)... GA (PRWEB) , ... December 07, 2016 , ... In ... route to respond to an emergency medical call when he lost control of his ... After being extricated from his vehicle, he was transported to Atlanta Medical Center, where ...
(Date:12/7/2016)... ... 07, 2016 , ... Levels of a protein in the blood associated with ... online in the journal Radiology. , Heart disease and brain disease exact a major ... rapidly aging population. Damage to both organs often occurs at a subclinical stage, or ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... services from offices located in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, ... coach who needs treatment for a brain tumor. , Jason Bauer and his ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... LONDON , Dec. 7,2016  Based ... drug delivery industry, Frost & Sullivan recognizes ... Frost & Sullivan Award for Enabling Technology ... plug the loopholes in traditional drug delivery ... and liquid microneedle-based drug delivery technologies, Memspatch ...
(Date:12/7/2016)... 7, 2016  Lannett Company, Inc. (NYSE: LCI ) ... Markets 2016 Prescription for Success Healthcare Conference on December 14, 2016 ... New York City . In addition, the ... Guggenheim Securities 4 th Annual Boston Healthcare Conference taking place ... ...
(Date:12/6/2016)... YORK , Dec. 6, 2016 Radioisotopes ... nucleus. Radioisotopes are produced either by using nuclear research ... in the form of alpha, beta or gamma when ... emitted are used in Nuclear medicine, specifically in medical ... provide diagnostic information about a human body,s functioning. Radiotherapy ...
Breaking Medicine Technology: